异质性和个性化治疗与多炎的eosinophilic颗粒瘤症
1Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Therapeutic advances in respiratory disease
|February 21, 2025
概括
带有多炎 (EGPA) 的异性粒状炎是一种复杂的血管炎,其原因和症状各异. 了解它的异质性是开发个性化治疗的关键,包括有针对性的生物疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 遗传学 是一个遗传学.
背景情况:
- 带有多炎的异性颗粒炎 (EGPA) 是抗中性粒细胞体抗体相关的血管炎中的异质状况.
- EGPA涉及各种环境/遗传因素,免疫成分,并呈现出影响多个器官系统的多种临床表现.
- 传统的治疗方法,如葡萄糖皮质激素和免疫抑制剂缺乏普遍适用性,特别是在复发或耐药病例.
研究的目的:
- 审查EGPA病因和病变的异质性.
- 讨论各种临床和病理表现,包括性别差异.
- 突出新兴的治疗方法,特别是针对2型炎症的生物治疗方法.
主要方法:
- 对EGPA病因,病原和治疗现有文献的综述.
- 分析不同器官系统的临床和病理异质性.
- 在EGPA管理中评估生物疗法的疗效.
主要成果:
- 在其根本原因,呈现和器官参与方面,EGPA表现出显著的异质性.
- 针对2型炎症的生物治疗对于缓解诱导和维持缓解是有效的,减少了葡萄糖皮质激素的依赖.
- 尽管取得了进展,但对于具有特定器官参与的耐火EGPA需要进一步研究.
结论:
- EGPA的特点是具有高度异质的表型谱.
- 针对关键致病分子的个性化治疗策略对于有效的EGPA管理至关重要.
- 有针对性的生物疗法在治疗EGPA方面取得了重大进展,改善了治疗结果并减少了对传统疗法的依赖.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
127
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
127
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
229
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
229